Results 21 to 30 of about 37,898 (281)

A horse of a different colour: distinct mechanisms of HFpEF and HFrEF [PDF]

The Journal of Physiology, 2020
William E. Louch, William E. Louch
openaire   +4 more sources

NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEF.

JACC. Heart failure, 2019
M. Daubert, K. Adams, E. Yow, H. Barnhart, P. Douglas, Susan Rimmer, C. Norris, L. Cooper, E. Leifer, P. Desvigne‐Nickens, K. Anstrom, M. Fiuzat, J. Ezekowitz, D. Mark, C. O'connor, J. Januzzi, G. Felker   +16 more
semanticscholar   +2 more sources

Polypill Eligibility for Patients with Heart Failure with Reduced Ejection Fraction in the ASIAN-HF Registry: A Cross-Sectional Analysis

Global Heart, 2023
Background: The rates of guideline-directed medical therapy (GDMT) prescription for heart failure with reduced ejection fraction (HFrEF) in Asia remain sub-optimal.
Aishwarya Vijay, Wan Ting Tay, Tiew-Hwa K. Teng, Kanako Teramoto, Jasper Tromp, Wouter Ouwerkerk, Seet Yoong Lo, Wataru Shimizu, Mark D. Huffman, Carolyn S. P. Lam, Chanchal Chandramouli, Anubha Agarwal   +11 more
doaj   +1 more source

Clinical characteristics and outcomes of heart failure with preserved, mildly reduced, and reduced ejection fraction: A 6-month follow-up study

Medical Journal of Babylon, 2022
Background and Objective: Heart failure is a major public health problem with 64.3 million people affected all over the world, and it is an important cause for hospital admission and mortality.
Goran Adnan Rahman, Abdulkareem Abdulwahab Al-Othman   +1 more
doaj   +1 more source

Renal function and the effects of vericiguat in patients with worsening heart failure with reduced ejection fraction: insights from the VICTORIA (Vericiguat Global Study in Subjects with HFrEF) trial

European Journal of Heart Failure, 2021
Vericiguat reduced the primary composite outcome of cardiovascular death or heart failure (HF) hospitalization in patients with worsening HF with reduced ejection fraction (HFrEF) and a lower limit of baseline estimated glomerular filtration rate (eGFR ...
A. Voors, H. Mulder, E. Reyes, M. Cowie, Johan Lassus, A. Hernandez, J. Ezekowitz, J. Butler, C. O'connor, J. Koglin, Carolyn S. P. Lam, B. Pieske, L. Roessig, P. Ponikowski, K. Anstrom, P. Armstrong   +15 more
semanticscholar   +1 more source

Left atrial structure and function in heart failure with reduced (HFrEF) versus preserved ejection fraction (HFpEF): systematic review and meta-analysis

Heart Failure Reviews, 2022
Left atrial (LA) structure and function in heart failure with reduced (HFrEF) versus preserved ejection fraction (HFpEF) is only established in small studies.
Xuanyi Jin, J. F. Nauta, C. Hung, W. Ouwerkerk, T. Teng, A. Voors, C. Lam, J. V. van Melle   +7 more
semanticscholar   +1 more source

The four pillars of HFrEF therapy: is it time to treat heart failure regardless of ejection fraction?

European Heart Journal, Supplement, 2022
The syndrome of heart failure (HF) has historically been dichotomized based on clinical trial inclusion criteria into patients with a reduced or preserved left ventricular ejection fraction (LVEF) using a cut-off of above or below 40%.
K. Docherty, A. Bayés‐Genís, J. Butler, A. Coats, M. Drazner, E. Joyce, Carolyn S. P. Lam   +6 more
semanticscholar   +1 more source

(Optimizing Foundational Therapies in Patients With HFrEF. How Do We Translate These Findings Into Clinical Care? Translation of the document prepared by the Czech Society of Cardiology)

Cor et Vasa, 2022
Tento článek prosím citujte takto: Málek F. Táborský M. Optimalizace léčby s použitím základních léků u pacientů se srdečním selháním se sníženou ejekční frakcí (HFrEF). Jak uplatňujeme nové poznatky v klinické praxi?
F. Málek, M. Táborský
semanticscholar   +1 more source

Prolonged central circulation transit time in patients with HFpEF and HFrEF by magnetic resonance imaging [PDF]

European Heart Journal-Cardiovascular Imaging, 2018
J. Cao, Laura Li, J. Mclaughlin, Michael Passick   +3 more
semanticscholar   +2 more sources

Management of heart failure with reduced ejection fraction: challenges in patients with atrial fibrillation, renal disease and in the elderly [PDF]

Reviews in Cardiovascular Medicine, 2022
Heart failure with reduced ejection fraction (HFrEF) is an increasing global pandemic affecting more than 30 million individuals worldwide. Importantly, HFrEF is frequently accompanied by the presence of cardiac and non-cardiac comorbidities that may ...
Yotam Kolben, Asa Kessler, Gal Puris, Dean Nachman, Paulino Alvarez, Alexandros Briasoulis, Rabea Asleh   +6 more
doaj   +1 more source